This week's top stories include breaking FDA approvals, insights on AI-assisted front desk management, and more.
|Videos|March 31, 2021
Video: Contact lenses will do more than correct refractive error
Contact lenses have more to offer than only refractive error correction
Advertisement
Contact lenses have more to offer than only refractive error correction, according to Lyndon Jones, PhD, FCAHS, FCOptom, FAAO, director of the Centre for Ocular Research & Education at the University of Waterloo School of Optometry. Jones is lead author on a recent
The full paper is open access and available to all:
Advertisement
Related to this article
Open-access OCTA tools showed similar reliability, but different vessel density values in glaucoma; researchers advise using one tool consistently.
Interim 48-month data show 86% of patients with glaucoma or ocular hypertension remain off topical drops after a single cataract procedure, although the drop-free rate has eased from earlier timepoints.
CLARITY program data show significantly longer time to treatment failure and higher rates of steroid-free quiescence vs placebo.
Drs Bryce St. Clair and Behrad Garmsiri explain how they build trust, improve health literacy, and destigmatize future interventions for patients with AMD.
Diana Canto-Sims, OD, introduces the second guest of Season 2, Raphael Rostenne, who will be discussing AI-assisted front desk management.
Duravyu gained 2.5 letters vs 6.1 with aflibercept at week 52/56, missing noninferiority in a second phase 3 wet AMD trial.
Alcon's Brytly eye drops received FDA approval for OTC temporary relief of minor ocular redness.
Advertisement
Advertisement
Trending on Optometry Times - Clinical News & Expert Optometrist Insights
1
Study: OCTA analysis tools report different macular vessel density values for glaucoma
2
Takeaways from this week in optometry: October 16-23
3
BIM-IOL System holds 37% IOP reduction at 4 years in first-in-human trial
4
Brepocitinib for noninfectious uveitis meets all phase 3 trial end points
5